Global private equity firm Permira has appointed David Floyd as a senior adviser to its global Healthcare team. Floyd brings over 35 years of experience in healthcare with a particular focus on the medical device industry.
Floyd’s professional experience spans international leadership roles including group president of orthopaedics, Stryker Corporation from 2012 to 2019, where he oversaw a number of acquisitions – most notably Mako Surgical, and also Instratek, Small Bone Innovations and Stanmore Implants.
He was previously worldwide president, DePuy Orthopaedics (nowy DePuy Synthes) initially with US responsibility, before being promoted to global responsibility, and also worked at Abbott Laboratories, where his roles included president of spine products.
David currently serves as Chairman of Corin Group, a tech-enabled orthopaedic implant company in which the Permira funds invested in 2018.
Permira is an active investor in the Healthcare sector, having deployed over €4 billion to partner with ~20 companies globally. Current investments from the Permira funds in the sector include: Kedrion and BPL, Neuraxpharm, Cambrex, Quotient Sciences, I-Med and Corin.
